Aura Biosciences AURA Cash Flow Statement (2020-2026)

NASDAQ AURA
$7.49 +0.12 (+1.63%)
As of: Sep 4, 2026 · 2:28 PM EDT
Reported Financials

Aura Biosciences Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

Aura Biosciences reported cash from operations of -$32.50M and free cash flow of -$33.07M for the quarter ended Jun 2026, down 56.5% year over year. This cash flow statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-8.89M-11.63M-12.81M-13.82M-16.05M-17.61M-17.47M-18.30M-18.51M-22.13M-19.71M-20.34M-21.04M-7.48M-27.48M-27.02M-26.13M-3.99M-33.69M-45.64M
Share-based CompensationStock Comp.
3.16M1.30M4.28M4.14M4.26M16.61M4.89M4.63M4.73M2.60M5.96M6.05M5.75M2.94M6.58M6.86M14.60M3.28M19.30M26.20M
Gains from Investment SecuritiesGains Investment
0.01M0.04M-0.06M
Cash from OperationsCash from Ops.
-8.69M-12.09M-15.20M-10.63M-10.76M-18.01M-16.41M-14.64M-15.40M-17.39M-24.45M-16.13M-15.27M-23.95M-23.36M-20.77M-20.14M-20.47M-29.89M-32.50M
Change in Working Capital
Change in Account PayablesChange Payables
-0.72M0.16M-0.76M-0.76M0.84M1.02M-1.88M-0.50M0.89M0.46M0.02M-0.54M0.69M0.31M-0.30M-0.72M0.60M-0.43M1.02M-0.33M
Change in Accured ExpensesChange Accured Exp.
1.11M0.85M-1.83M1.43M1.34M-0.70M-0.51M1.27M1.03M1.51M-2.90M1.35M3.14M-0.02M-2.48M3.38M3.35M-0.12M-2.75M3.17M
Investing Activities
Capital ExpendituresCapex
0.57M0.82M0.60M0.07M0.06M0.36M0.20M0.10M0.09M0.32M0.12M0.49M0.34M0.30M-0.52M0.18M0.60M0.18M0.10M0.57M
Change in Acquisitions & DivestmentsChange Acquisitions
18.00M32.01M22.08M21.60M21.72M55.00M99.18M30.00M30.00M30.00M30.00M30.00M55.00M30.00M
Cash from Investing ActivitiesCash from Investing
-0.57M-0.82M-25.50M-43.44M17.95M-16.88M-66.88M21.41M21.63M-90.12M9.40M19.84M9.89M29.70M29.81M19.98M-44.02M29.82M54.90M-226.03M
Financing Activities
Other financing activitiesOther financing
0.02M78.39M0.02M0.31M0.10M86.22M0.14M0.66M0.20M91.61M0.16M0.08M0.63M0.54M0.10M14.06M0.12M21.26M
Cash from Financing ActivitiesCash from Financing
-1.12M80.14M0.02M0.31M0.10M95.20M0.20M2.48M1.63M92.98M0.25M0.08M0.72M0.54M0.10M69.93M4.36M2.77M0.30M241.75M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
2.97M0.10M0.54M0.76M1.61M1.09M1.65M1.06M1.60M1.64M
Net Equity Issued and RepurchasedNet Equity Issued
-1.55M1.20M3.90M
Additional items
Exchange Rate EffectFX Effect
-0.02M0.01M-0.01M-0.16M-0.03M-0.17M
Change in Cash
-10.38M67.24M-40.68M-53.76M7.29M60.31M-83.09M9.24M7.85M-14.52M-14.80M3.80M-4.67M6.29M6.55M69.13M-59.80M12.12M25.30M-16.78M
Free Cash FlowFCF
-9.26M-12.90M-15.80M-10.70M-10.82M-18.37M-16.61M-14.75M-15.49M-17.70M-24.57M-16.62M-15.61M-24.25M-22.84M-20.96M-20.75M-20.64M-30.00M-33.07M
Net Cash FlowNCF
-10.38M67.24M-40.68M-53.76M7.29M60.31M-83.09M9.24M7.85M-14.52M-14.80M3.80M-4.67M6.29M6.55M69.13M-59.80M12.12M25.30M-16.78M